BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22586066)

  • 1. Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo.
    Schiefer A; Schmitz A; Schäberle TF; Specht S; Lämmer C; Johnston KL; Vassylyev DG; König GM; Hoerauf A; Pfarr K
    J Infect Dis; 2012 Jul; 206(2):249-57. PubMed ID: 22586066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corallopyronin A - a promising antibiotic for treatment of filariasis.
    Schäberle TF; Schiefer A; Schmitz A; König GM; Hoerauf A; Pfarr K
    Int J Med Microbiol; 2014 Jan; 304(1):72-8. PubMed ID: 24079981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
    Schiefer A; Hübner MP; Krome A; Lämmer C; Ehrens A; Aden T; Koschel M; Neufeld H; Chaverra-Muñoz L; Jansen R; Kehraus S; König GM; Pogorevc D; Müller R; Stadler M; Hüttel S; Hesterkamp T; Wagner K; Pfarr K; Hoerauf A
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008930. PubMed ID: 33284808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis.
    Ehrens A; Lunde CS; Jacobs RT; Struever D; Koschel M; Frohberger SJ; Lenz F; Fendler M; Turner JD; Ward SA; Taylor MJ; Freund YR; Stefanakis R; Easom E; Li X; Plattner JJ; Hoerauf A; Hübner MP
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007957. PubMed ID: 31986143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability.
    Volkmann L; Fischer K; Taylor M; Hoerauf A
    Trop Med Int Health; 2003 May; 8(5):392-401. PubMed ID: 12753632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
    Aljayyoussi G; Tyrer HE; Ford L; Sjoberg H; Pionnier N; Waterhouse D; Davies J; Gamble J; Metuge H; Cook DAN; Steven A; Sharma R; Guimaraes AF; Clare RH; Cassidy A; Johnston KL; Myhill L; Hayward L; Wanji S; Turner JD; Taylor MJ; Ward SA
    Sci Rep; 2017 Mar; 7(1):210. PubMed ID: 28303006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The symbiotic role of Wolbachia in Onchocercidae and its impact on filariasis.
    Bouchery T; Lefoulon E; Karadjian G; Nieguitsila A; Martin C
    Clin Microbiol Infect; 2013 Feb; 19(2):131-40. PubMed ID: 23398406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ClpP peptidase of Wolbachia endobacteria is a novel target for drug development against filarial infections.
    Schiefer A; Vollmer J; Lämmer C; Specht S; Lentz C; Ruebsamen-Schaeff H; Brötz-Oesterhelt H; Hoerauf A; Pfarr K
    J Antimicrob Chemother; 2013 Aug; 68(8):1790-800. PubMed ID: 23584755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of a filarial phosphate permease that is up-regulated in response to depletion of essential Wolbachia endobacteria.
    Arumugam S; Hoerauf A; Pfarr KM
    Exp Parasitol; 2014 Mar; 138():30-9. PubMed ID: 24480589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics which target the Wolbachia endosymbionts of filarial parasites: a new strategy for control of filariasis and amelioration of pathology.
    Pfarr KM; Hoerauf AM
    Mini Rev Med Chem; 2006 Feb; 6(2):203-10. PubMed ID: 16472187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin.
    Hoerauf A; Volkmann L; Nissen-Paehle K; Schmetz C; Autenrieth I; Büttner DW; Fleischer B
    Trop Med Int Health; 2000 Apr; 5(4):275-9. PubMed ID: 10810023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model.
    Specht S; Pfarr KM; Arriens S; Hübner MP; Klarmann-Schulz U; Koschel M; Sternberg S; Martin C; Ford L; Taylor MJ; Hoerauf A
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006116. PubMed ID: 29300732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wolbachia endosymbiotic bacteria of filarial nematodes. A new insight into disease pathogenesis and control.
    Taylor MJ
    Arch Med Res; 2002; 33(4):422-4. PubMed ID: 12234534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.
    von Geldern TW; Morton HE; Clark RF; Brown BS; Johnston KL; Ford L; Specht S; Carr RA; Stolarik DF; Ma J; Rieser MJ; Struever D; Frohberger SJ; Koschel M; Ehrens A; Turner JD; Hübner MP; Hoerauf A; Taylor MJ; Ward SA; Marsh K; Kempf DJ
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007159. PubMed ID: 30818326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wolbachia bacteria of filarial nematodes: a target for control?
    Taylor MJ; Bandi C; Hoerauf AM; Lazdins J
    Parasitol Today; 2000 May; 16(5):179-80. PubMed ID: 10782070
    [No Abstract]   [Full Text] [Related]  

  • 16. Wolbachia filarial interactions.
    Taylor MJ; Voronin D; Johnston KL; Ford L
    Cell Microbiol; 2013 Apr; 15(4):520-6. PubMed ID: 23210448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wolbachia in filarial nematodes: evolutionary aspects and implications for the pathogenesis and treatment of filarial diseases.
    Bandi C; Trees AJ; Brattig NW
    Vet Parasitol; 2001 Jul; 98(1-3):215-38. PubMed ID: 11516587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endosymbiont Wolbachia rebounds following antibiotic treatment.
    Gunderson EL; Vogel I; Chappell L; Bulman CA; Lim KC; Luo M; Whitman JD; Franklin C; Choi YJ; Lefoulon E; Clark T; Beerntsen B; Slatko B; Mitreva M; Sullivan W; Sakanari JA
    PLoS Pathog; 2020 Jul; 16(7):e1008623. PubMed ID: 32639986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.
    Bakowski MA; Shiroodi RK; Liu R; Olejniczak J; Yang B; Gagaring K; Guo H; White PM; Chappell L; Debec A; Landmann F; Dubben B; Lenz F; Struever D; Ehrens A; Frohberger SJ; Sjoberg H; Pionnier N; Murphy E; Archer J; Steven A; Chunda VC; Fombad FF; Chounna PW; Njouendou AJ; Metuge HM; Ndzeshang BL; Gandjui NV; Akumtoh DN; Kwenti TDB; Woods AK; Joseph SB; Hull MV; Xiong W; Kuhen KL; Taylor MJ; Wanji S; Turner JD; Hübner MP; Hoerauf A; Chatterjee AK; Roland J; Tremblay MS; Schultz PG; Sullivan W; Chu XJ; Petrassi HM; McNamara CW
    Sci Transl Med; 2019 May; 11(491):. PubMed ID: 31068442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Litomosoides sigmodontis: vaccine-induced immune responses against Wolbachia surface protein can enhance the survival of filarial nematodes during primary infection.
    Lamb TJ; Harris A; Le Goff L; Read AF; Allen JE
    Exp Parasitol; 2008 Feb; 118(2):285-9. PubMed ID: 17919582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.